Document is current
Any future updates will be listed below
-
Authors
Nagaraja, Surya
Ojeda-Miron, Lety https://orcid.org/0009-0005-3747-1628
Zhang, Ruochi https://orcid.org/0000-0002-1103-5044
Oreskovic, Ena
Hock, Conrad
Hu, Yan https://orcid.org/0000-0002-8435-6586
Zeve, Daniel
Sharma, Karina
Hyman, Roni R.
Zhang, Qiming https://orcid.org/0000-0003-4282-2996
Castillo, Andrew
Breault, David T. https://orcid.org/0000-0002-0402-4857
Yilmaz, Ömer H. https://orcid.org/0000-0002-7577-4612
Buenrostro, Jason D. https://orcid.org/0000-0001-9958-3987
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 10 February 2026
First Online: 25 March 2026
Competing interests
: J.D.B. holds patents related to ATAC-seq, is on the scientific advisory board for Camp4 and seqWell, is a co-founder of Switchpoint Bio, and is a consultant at the Treehouse Family Foundation. O.H.Y. holds equity in Jumbl therapeutics and Ava Bioscience and consults for Nestle and Prescrypt therapeutics. The remaining authors declare no competing interests.
